Innovex International (INVX) Faces A Share Offering, Is The Stock Still Fully Valued?
Stock offering and ownership shift at Innovex International
The latest move around Innovex International (INVX) centers on a follow on equity offering of 5,000,000 common shares, priced and sold by affiliates of Amberjack Capital Partners rather than the company itself.
Innovex International will not receive cash from this transaction, since the selling shareholders are the ones disposing of stock. For you as an investor, the focus is on how this larger freely traded float relates to recent operating results and the company’s current acquisition plans.
See our latest analysis for Innovex International.
After the Amberjack follow on offering news, Innovex International’s share price closed at $28.10. The 1 day share price return declined 8.47%, while the 30 day share price return is up 10.33% and the 1 year total shareholder return sits at 73.46%. This signals that recent momentum has cooled after a strong run supported by second quarter earnings, guidance for third quarter revenue of $260 million to $270 million, and fresh comments about a busy acquisition pipeline.
If this kind of activity has you thinking about where else to put fresh capital to work in energy linked infrastructure, it can be worth scanning a broader set of grid focused contractors and equipment providers through the 37 power grid technology and infrastructure stocks
After the Amberjack offering and a sharp single day drop, Innovex International still trades at a discount to both analyst targets and some intrinsic estimates. Is the market rightly cautious, or is the gap now too wide?
Most Popular Narrative: 8.1% Overvalued
On the widely followed narrative, Innovex International screens slightly above its implied fair value of $26.00 per share, compared with the latest close at $28.10. The gap is not huge, which is why the underlying earnings and margin story matters so much.
The assumed bearish price target for Innovex International is $26.0, which represents up to two standard deviations below the consensus price target of $33.0. This valuation is based on what can be assumed as the expectations of Innovex International's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
Want to see what sits behind that $26.00 fair value? The narrative leans heavily on margin expansion, measured revenue growth and a future earnings multiple that is well below where many peers trade today. Curious how those pieces fit together into one pricing story?
Result: Fair Value of $26.00 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the fair value story for Innovex International can still be challenged if offshore project timing slips again or if further legal costs absorb more of that cash pile.
Find out about the key risks to this Innovex International narrative.
Another View on Innovex International’s Value
While the narrative driven fair value for Innovex International sits at $26.00 and implies the stock is 8.1% overvalued, the Simply Wall St DCF model points in the opposite direction. That model suggests shares trade at a very wide discount to estimated future cash flows.
The gap between a story based multiple approach and a cash flow based model is large enough that investors may want to stress test their own assumptions. Which set of inputs feels more realistic when you think about Innovex International’s project timing, margins and capital allocation?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Innovex International for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
If the mixed signals around Innovex International leave you unsure, review the details yourself soon and consider both sides of the story with the 1 key reward and 1 important warning sign
Looking for more investment ideas beyond Innovex International?
If Innovex International has sharpened your interest, do not stop here. Broader opportunities can help balance risk, sharpen conviction and keep you ahead of the next move.
- Target steadier compounding by focusing on companies priced below their estimated worth through the 52 high quality undervalued stocks
- Strengthen your income stream by scanning companies that aim to support higher payouts with the 8 dividend fortresses
- Prioritise resilience by reviewing companies that pair robust finances with calmer risk profiles using the 83 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com